comparemela.com

Latest Breaking News On - Silo pharma inc - Page 18 : comparemela.com

Financialnewsmedia com: Global Alzheimer s Disease Diagnostics & Therapeutics Market Expected to Reach $9 6 Billion by 2027

Silo Pharma s SPC-15 Awarded U S Patent Protecting Ongoing

ENGLEWOOD CLIFFS, NJ, May 09, 2023 (GLOBE NEWSWIRE) Silo Pharma, Inc.  (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company.

Reviewing G-III Apparel Group (NASDAQ:GIII) & Silo Pharma (NASDAQ:SILO)

G-III Apparel Group (NASDAQ:GIII – Get Rating) and Silo Pharma (NASDAQ:SILO – Get Rating) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Institutional & Insider Ownership 88.8% of G-III […]

Comparing Silo Pharma (NASDAQ:SILO) & G-III Apparel Group (NASDAQ:GIII)

G-III Apparel Group (NASDAQ:GIII – Get Rating) and Silo Pharma (NASDAQ:SILO – Get Rating) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Institutional & Insider Ownership 88.8% of G-III […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.